Literature DB >> 2530478

Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses.

A G Phillips1, C D Blaha, H C Fibiger.   

Abstract

Evidence from ex vivo analyses of dopaminergic function following self-stimulation behavior is reviewed and compared to in vivo analyses of extracellular dopamine measured by chronoamperometry during self-stimulation. Both data bases provide strong support for a dopaminergic substrate for brain-stimulation reward obtained by electrical stimulation of the ventral tegmental area (VTA). Data obtained from in vivo measures of dopamine release are particularly compelling as a positive correlation was observed between the rate/intensity function for self-stimulation and increments in the oxidation current for dopamine. An examination of the effects of the dopamine uptake blockers, cocaine and GBR 12909 on self-stimulation and stimulated release of dopamine revealed a facilitation of both measures. In contrast, the noradrenaline uptake blocker desipramine had no effect on either self-stimulation or extracellular dopamine. These pharmacological experiments also are consistent with a dopaminergic substrate of brain-stimulation reward at electrode sites in the VTA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530478     DOI: 10.1016/s0149-7634(89)80017-x

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  23 in total

1.  Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Authors:  J Elliott Robinson; Abigail E Agoglia; Eric W Fish; Michael C Krouse; C J Malanga
Journal:  Behav Brain Res       Date:  2012-06-21       Impact factor: 3.332

2.  Electrical stimulation of the ventral tegmental area induces reanimation from general anesthesia.

Authors:  Ken Solt; Christa J Van Dort; Jessica J Chemali; Norman E Taylor; Jonathan D Kenny; Emery N Brown
Journal:  Anesthesiology       Date:  2014-08       Impact factor: 7.892

3.  Chronic low-dose haloperidol effects on self-stimulation rate-intensity functions.

Authors:  M R Lynch; R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Modulating dopamine release by optogenetics in transgenic mice reveals terminal dopaminergic dynamics.

Authors:  Yao Lu; Nicolette Driscoll; Ilker Ozden; Zeyang Yu; Arto V Nurmikko
Journal:  Neurophotonics       Date:  2015-07-09       Impact factor: 3.593

5.  Medial forebrain bundle lesions fail to structurally and functionally disconnect the ventral tegmental area from many ipsilateral forebrain nuclei: implications for the neural substrate of brain stimulation reward.

Authors:  J M Simmons; R F Ackermann; C R Gallistel
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

6.  The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

Authors:  Svetlana Semenova; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2010-06-03       Impact factor: 4.600

Review 7.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

8.  Facilitation of brain stimulation reward by MK-801 (dizocilpine) may be independent of D2-like dopamine receptor stimulation in rats.

Authors:  R L H Clements; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

9.  Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response.

Authors:  Andre Der-Avakian; Michelle S Mazei-Robison; James P Kesby; Eric J Nestler; Athina Markou
Journal:  Biol Psychiatry       Date:  2014-01-31       Impact factor: 13.382

10.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.